We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
BIOSENTA Inc | CSE:ZRO | CSE | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.275 | 0.27 | 0.28 | 0.275 | 0.275 | 0.275 | 500 | 14:35:10 |
BIOSENTA INC. ("Biosenta" or the "Company") (CSE:ZRO), is pleased to announce that it has completed a sales listing agreement with one of Canada's largest grocery retailers for ZeroMold(TM) to be sold across the country. Shipments of ZeroMold(TM) to this retailer commenced on June 9. This listing agreement represents the SECOND national retail distribution agreement announced by Biosenta which places the Company ahead of the milestones announced on March 27, 2014, whereby the first two distribution agreements were expected on or before June 30. The Company continues to work towards broadening the availability of ZeroMold(TM) through national retailers across Canada. "We are pleased to be able to offer ZeroMold(TM) to our customers through one of Canada's largest retailers," says Biosenta CEO Chris Bilz. "ZeroMold(TM) is a perfect solution for any household that has encountered mold of any kind in bathrooms, basements and even on garden furniture because unlike many other cleaning products, ZeroMold(TM) actually kills the mold spores that affect personal health rather than just cleaning the blackened area that can be seen by the naked eye. We are excited to make this product available on an ever expanding basis through recognized retailers across Canada." About Biosenta Inc. Biosenta Inc.'s line of retail anti-microbial products will effectively kill mould, bacteria and fungi on contact and prevent re-growth. These products address the demand created by the mounting health and environmental concerns. Mould can affect the immune system, nervous system, liver, kidneys, blood and can cause brain damage. On behalf of the Board of Directors of Biosenta Inc. Chris Bilz, CEO & President The CNSX has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this press release. Neither the CNSX nor its Regulation Services Provider (as such term is defined in the policies of the CNSX) accepts responsibility for the adequacy or accuracy of this release. FOR FURTHER INFORMATION PLEASE CONTACT: BIOSENTA Inc. Chris Bilz CEO & President (416) 410 2019 BIOSENTA Inc. 1120 Finch Avenue West, Suite 503, Toronto, Ontario M3J 3H7 Investor Cubed Inc. Neil Simon Investor Relations 647-258-3311 or 888-258-3323 info@investor3.ca
1 Year BIOSENTA Chart |
1 Month BIOSENTA Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions